|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-3-319-24741-0 |
003 |
DE-He213 |
005 |
20220114194705.0 |
007 |
cr nn 008mamaa |
008 |
151207s2016 sz | s |||| 0|eng d |
020 |
|
|
|a 9783319247410
|9 978-3-319-24741-0
|
024 |
7 |
|
|a 10.1007/978-3-319-24741-0
|2 doi
|
050 |
|
4 |
|a RC434.2-574
|
072 |
|
7 |
|a MMH
|2 bicssc
|
072 |
|
7 |
|a MED105020
|2 bisacsh
|
072 |
|
7 |
|a MKL
|2 thema
|
082 |
0 |
4 |
|a 616.89
|2 23
|
245 |
1 |
0 |
|a Pharmacovigilance in Psychiatry
|h [electronic resource] /
|c edited by Edoardo Spina, Gianluca Trifirò.
|
250 |
|
|
|a 1st ed. 2016.
|
264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Adis,
|c 2016.
|
300 |
|
|
|a XI, 319 p. 12 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a 1. Introduction: History of pharmacovigilance in psychiatry -- 2. Adverse drug reactions: definition and pathogenesis -- 3. Methodologies for pharmacovigilance monitoring of psychotropic drugs -- 4. The role of prescription event monitoring in pharmacovigilance of psychotropic drugs -- 5. The role of healthcare databases in pharmacovigilance of psychotropic drugs -- 6. Monitoring of plasma concentrations of psychotropic drugs in pharmacovigilance -- 7. The role of pharmacogenetics in pharmacovigilance of psychotropic drugs -- 8. Safety and tolerability of antidepressants -- 9. Safety and tolerability of antipsychotics -- 10. Safety and tolerability of anxiolytics/sedative hypnotics -- 11. Safety and tolerability of mood stabilizers -- 12. Safety and tolerability of medications for ADHD -- 13. Safety of psychotropic drugs in children and adolescents -- 14. Safety of psychotropic drugs in the elderly(Safety of psychotropic drugs in the elderly -- 15. Safety of psychotropic drugs in pregnancy and breastfeeding.
|
520 |
|
|
|a The first authoritative textbook specifically addressing issues of the field, this book delivers a focused discussion on several themes in psychiatry while providing a sound background on pharmacovigilance. Internationally-recognised researchers, clinicians and pharmacovigilance experts contributed to this textbook, giving it the benefit of different perspectives and years of experience. Pharmacovigilance in psychiatry provides a thorough introduction to this field but goes on to explore advanced themes such as methodologies and resources used for pharmacovigilance in psychiatry, challenges as well as most recent developments to this field, making it suitable for under-graduates, graduate and post-doctoral students and persons working pharmacovigilance who seek to broaden their knowledge on this subject.
|
650 |
|
0 |
|a Psychiatry.
|
650 |
|
0 |
|a Pharmacovigilance.
|
650 |
1 |
4 |
|a Psychiatry.
|
650 |
2 |
4 |
|a Drug Safety and Pharmacovigilance.
|
700 |
1 |
|
|a Spina, Edoardo.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Trifirò, Gianluca.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319247397
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319247403
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319796703
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-3-319-24741-0
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|